Skip to content

Diagnosis and pathological analysis of intestinal bacterial overgrowth (SIBO)

Diagnosis and pathological analysis of intestinal bacterial overgrowth (SIBO) - SIBO

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033715
Enrollment
30
Registered
2018-08-10
Start date
2018-08-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small intestinal bacterial overgrowth

Interventions

None listed

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who visited Shiga University Medical School affiliated hospital 2. Those with abdominal symptoms such as abdominal distension and abdominal pain 3. Abdominal simple X-ray examination recognizes small intestinal gas or recognizes intestinal fecal sign by CT examination 4. Excluding organic diseases of the upper digestive tract is considered necessary, and those scheduled to undergo upper gastrointestinal endoscopy 5. Those who do not allow administration of antibiotics for at least 3 months prior to acquiring study participation consent 6. If probiotics has been prescribed, those that can be discontinued one week before entering intestinal fluid sampling and breath test 7. Those who can acquire the consent by free will from the principal in writing

Exclusion criteria

Exclusion criteria: 8. Those who can not obtain consent 9. Diabetic patients who have poor glycemic control (in cases where marked hyperglycemia is expected with 50 g of glucose) 10. Those who are pregnant or suspected pregnancy 11. Those who have mental illness and have difficulty agreeing to this exam 12. What doctors deem inappropriate for participation in research

Design outcomes

Primary

MeasureTime frame
The diagnostic ability (sensitivity, specificity, positive predictive value, negative predictive value) of breath test when quantitative culture of duodenal juice was taken as gold standard of SIBO diagnosis.

Countries

Japan

Contacts

Public ContactShigeki Bamba

Shiga University of Medical Science Division of Digestive Endoscopy

sb@belle.shiga-med.ac.jp0775482618

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026